Phenotypic identification of T lymphocytes subset in recurrent aphthous stomatitis. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Phenotypic identification of T lymphocytes subset in recurrent aphthous stomatitis.

Egypt Dent J. 1990 Jan;36(1):33-46. Unique Identifier : AIDSLINE MED/92233819
Abdel All M; Ayoub A; el Refai M; Faculty of Oral and Dental Medicine, Cairo University.


Abstract: Recurrent aphthous stomatitis (RAS) is characterized by recurring ulcers in the oral mucosa as abnormality of the immune response, autoimmune or abnormal immunological reaction to antigens of oral bacteria. This study was conducted on 25 patients 15 suffering RAS of the minor form and 10 of the major form and 15 student as control. The T lymphocytes were determined by the monoclonal antibodies (OKT) using the indirect immunofluorescent technique of Hoffman percentage of cells having surface fluorescence was calculated and the monoclonal antibody coated cells visualized and enumerated. It was concluded from this study that the two clinical entities of RAS may be of the same immunopathologic etiology but the difference lies in the T cell subpopulation and the ratio of T helper to T suppressor T4/T8.
Keywords: Adolescence Adult Antibodies, Monoclonal/DIAGNOSTIC USE CD4-CD8 Ratio Fluorescent Antibody Technique Human Phenotype Stomatitis, Aphthous/*IMMUNOLOGY *T-Lymphocyte Subsets T-Lymphocytes, Helper-Inducer T-Lymphocytes, Suppressor-Effector JOURNAL ARTICLEKWDadolescenceadultantibodies,monoclonal/diagnosticusecd4-cd8ratiofluorescentantibodytechniquehumanphenotypestomatitis,aphthous/KWDimmunologyKWDt-lymphocytesubsetst-lymphocytes,helper-inducert-lymphocytes,suppressor-effectorjournalarticle
920730
M9271071

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .